David H. Sachs
Corporate Officer/Principal bei Harvard Medical School
Profil
David H.
Sachs is the founder of Pandion Operations, Inc. (founded in 2017).
He is currently a Professor at Harvard Medical School (since 1991).
He has also held positions as a Director at Aphton Corp., Director-Transplantation Biology Research Center at The General Hospital Corp., and Director at Xeno Transplants Corp.
(2007-2012).
Aktive Positionen von David H. Sachs
Unternehmen | Position | Beginn |
---|---|---|
Harvard Medical School | Corporate Officer/Principal | 04.02.2010 |
Ehemalige bekannte Positionen von David H. Sachs
Unternehmen | Position | Ende |
---|---|---|
Aphton Corp.
Aphton Corp. BiotechnologyHealth Technology Aphton Corp. operates as a biopharmaceutical company, which is focused on the development and commercialization of pharmaceutical products for the treatment of cancer and gastrointestinal disease. The company was founded on May 12, 1981 and is headquartered in Philadelphia, PA. | Direktor/Vorstandsmitglied | 19.12.2006 |
Pandion Operations, Inc.
Pandion Operations, Inc. Miscellaneous Commercial ServicesCommercial Services Pandion Operations, Inc. develops drugs for autoimmune, inflammatory, and transplant indications. The company was founded by Anthony J. Coyle, Jo Viney, Alan Crane, and David Sachs in 2017 and is headquartered in Cambridge, MA. | Gründer | - |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
XENO TRANSPLANTS CORPORATION | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
XENO TRANSPLANTS CORPORATION | Health Technology |
Private Unternehmen | 3 |
---|---|
Aphton Corp.
Aphton Corp. BiotechnologyHealth Technology Aphton Corp. operates as a biopharmaceutical company, which is focused on the development and commercialization of pharmaceutical products for the treatment of cancer and gastrointestinal disease. The company was founded on May 12, 1981 and is headquartered in Philadelphia, PA. | Health Technology |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Health Services |
Pandion Operations, Inc.
Pandion Operations, Inc. Miscellaneous Commercial ServicesCommercial Services Pandion Operations, Inc. develops drugs for autoimmune, inflammatory, and transplant indications. The company was founded by Anthony J. Coyle, Jo Viney, Alan Crane, and David Sachs in 2017 and is headquartered in Cambridge, MA. | Commercial Services |